The orphan nuclear receptor EAR2 is overexpressed in colorectal cancer and it regulates survivability of colon cancer cells

Cancer Letters

Volumn 309, Issue 2, 2011, Pages 137-144

  Li, Xue bing ^a   Jiao, Shi ^a   Sun, Heng ^a   Xue, Jing ^a   Zhao, Wen ting ^a   Fan, Li ^a   Wu, Guo hao ^b   Fang, Jing ^a  

^a Chinese Academy of Sciences   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Colorectal cancer; EAR2; Orphan nuclear receptor

Indexed keywords

ORPHAN NUCLEAR RECEPTOR; ORPHAN NUCLEAR RECEPTOR EAR2; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL STRAIN HCT116; CELL STRAIN HEK293; CELL STRAIN HT29; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; RECEPTORS, STEROID; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 79960848742     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.05.025     Document Type: Article

References (39)

1. Beato M., Herrlich P., Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995, 83:851-857.
2. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell 1995, 83:841-850.
3. Kliewer S.A., Lehmann J.M., Willson T.M. Orphan nuclear receptors: shifting endocrinology into reverse. Science 1999, 284:757-760.
4. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
5. Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M., Mangelsdorf D.J. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 2006, 126:789-799.
6. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294:1866-1870.
7. D'Errico I., Moschetta A. Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell. Mol. Life Sci. 2008, 65:1523-1543.
8. Mulholland D.J., Dedhar S., Coetzee G.A., Nelson C.C. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?. Endocr. Rev. 2005, 26:898-915.
9. Tsai S.Y., Tsai M.J. Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age. Endocr. Rev. 1997, 18:229-240.
10. Germain P., Staels B., Dacquet C., Spedding M., Laudet V. Overview of nomenclature of nuclear receptors. Pharmacol. Rev. 2006, 58:685-704.
11. Takamoto N., You L.R., Moses K., Chiang C., Zimmer W.E., Schwartz R.J., DeMayo F.J., Tsai M.J., Tsai S.Y. COUP-TFII is essential for radial and anteroposterior patterning of the stomach. Development 2005, 132:2179-2189.
12. You L.R., Lin F.J., Lee C.T., DeMayo F.J., Tsai M.J., Tsai S.Y. Suppression of Notch signaling by COUP-TFII transcription factor regulates vein identity. Nature 2005, 435:98-104.
13. Pereira F.A., Qiu Y., Zhou G., Tsai M.J., Tsai S.Y. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev. 1999, 13:1037-1049.
14. Qiu Y., Pereira F.A., DeMayo F.J., Lydon J.P., Tsai S.Y., Tsai M.J. Null mutation of mCOUP-TFI results in defects in morphogenesis of the glossopharyngeal ganglion, axonal projection, and arborization. Genes Dev. 1997, 11:1925-1937.
15. Warnecke M., Oster H., Revelli J.P., Alvarez-Bolado G., Eichele G. Abnormal development of the locus coeruleus in Ear2(Nr2f6)-deficient mice impairs the functionality of the forebrain clock and affects nociception. Genes Dev. 2005, 19:614-625.
16. Zhou C., Qiu Y., Pereira F.A., Crair M.C., Tsai S.Y., Tsai M.J. The nuclear orphan receptor COUP-TFI is required for differentiation of subplate neurons and guidance of thalamocortical axons. Neuron 1999, 24:847-859.
17. Zhou C., Tsai S.Y., Tsai M. From apoptosis to angiogenesis: new insights into the roles of nuclear orphan receptors, chicken ovalbumin upstream promoter-transcription factors, during development. Biochim. Biophys. Acta 2000, 1470:M63-M68.
18. Zhou C., Tsai S.Y., Tsai M.J. COUP-TFI: an intrinsic factor for early regionalization of the neocortex. Genes Dev. 2001, 15:2054-2059.
19. Kruse S.W., Suino-Powell K., Zhou X.E., Krestchman J.E., Reynolds R., Vonrhein C., Xu Y., Wang L., Tsai S.Y., Tsai M.L., Xu H.E. Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biol. 2008, 6:e227.
20. Zhu X.G., Park K.S., Kaneshige M., Bhat M.K., Zhu Q., Mariash C.N., McPhie P., Cheng S.Y. The orphan nuclear receptor Ear-2 is a negative coregulator for thyroid hormone nuclear receptor function. Mol. Cell. Biol. 2000, 20:2604-2618.
21. Zhang Y., Dufau M.L. Nuclear orphan receptors regulate transcription of the gene for the human luteinizing hormone receptor. J. Biol. Chem. 2000, 275:2763-2770.
22. Liu X., Huang X., Sigmund C.D. Identification of a nuclear orphan receptor (Ear2) as a negative regulator of renin gene transcription. Circ. Res. 2003, 92:1033-1040.
23. Hermann-Kleiter N., Gruber T., Lutz-Nicoladoni C., Thuille N., Fresser F., Labi V., Schiefermeier N., Warnecke M., Huber L., Villunger A., Eichele G., Kaminski S., Baier G. The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity. Immunity 2008, 29:205-216.
24. Davies R.J., Miller R., Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat. Rev. Cancer 2005, 5:199-209.
25. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58:71-96.
26. Lee J.M., Kim I.S., Kim H., Lee J.S., Kim K., Yim H.Y., Jeong J., Kim J.H., Kim J.Y., Lee H., Seo S.B., Kim H., Rosenfeld M.G., Kim K.I., Baek S.H. RORalpha attenuates Wnt/beta-catenin signaling by PKCalpha-dependent phosphorylation in colon cancer. Mol. Cell 2010, 37:83-95.
27. Modica S., Gofflot F., Murzilli S., D'Orazio A., Salvatore L., Pellegrini F., Nicolucci A., Tognoni G., Copetti M., Valanzano R., Veschi S., Mariani-Costantini R., Palasciano G., Schoonjans K., Auwerx J., Moschetta A. The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors. Gastroenterology 2010, 138:636-648.
28. Xue J., Li X., Jiao S., Wei Y., Wu G., Fang J. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Gastroenterology 2010, 138:606-615.
29. Hu X.W., Meng D., Fang J. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis 2008, 29:2369-2376.
30. Miyajima N., Kadowaki Y., Fukushige S., Shimizu S., Semba K., Yamanashi Y., Matsubara K., Toyoshima K., Yamamoto T. Identification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each other. Nucl. Acids Res. 1988, 16:11057-11074.
31. Liston P., Fong W.G., Korneluk R.G. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 2003, 22:8568-8580.
32. Takeuchi H., Kim J., Fujimoto A., Umetani N., Mori T., Bilchik A., Turner R., Tran A., Kuo C., Hoon D.S. X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling. Clin. Cancer Res. 2005, 11:7621-7628.
33. X. Zhang, N. Tang, T.J. Hadden, A.K. Rishi. Akt, FoxO and regulation of apoptosis, Biochim. Biophys. Acta (2011) (Epub ahead of print).
34. Aggarwal B.B. Nuclear factor-κB: the enemy within. Cancer Cell 2004, 6:203-208.
35. Brady C.A., Attardi L.D. P53 at a glance. J. Cell Sci. 2010, 123:2527-2532.
36. Modica S., Murzilli S., Salvatore L., Schmidt D.R., Moschetta A. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res. 2008, 68:9589-9594.
37. Kallay E., Pietschmann P., Toyokuni S., Bajna E., Hahn P., Mazzucco K., Bieglmayer C., Kato S., Cross H.S. Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis 2001, 22:429-1435.
38. Saez E., Tontonoz P., Nelson M.C., Alvarez J.G., Ming U.T., Baird S.M., Thomazy V.A., Evans R.M. Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat. Med. 1998, 4:1058-1061.
39. Jiang H., Chen K., He J., Pan F., Li J., Chen J., Chen W., Liang H. Association of pregnane X receptor with multidrug resistance-related protein 3 and its role in human colon cancer chemoresistance. J. Gastrointest. Surg. 2009, 13:1831-1838.